Skip to Content

Pemazyre Prices, Coupons and Patient Assistance Programs

Pemazyre (pemigatinib) is a member of the multikinase inhibitors drug class and is commonly used for Cholangiocarcinoma of Biliary Tract.

Pemazyre Prices

The cost for Pemazyre oral tablet 4.5 mg is around $17,758 for a supply of 14 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Pemazyre is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Pemazyre availability.

This Pemazyre price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Oral Tablet Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Pemazyre Coupons and Rebates

Pemazyre offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Pemazyre IncyteCARES Copay/Coinsurance Program: Eligible commercially insured patients may pay as little as $0 copay with a savings of up to $25,000 per year; for additional information contact the program at 855-452-5234.

Applies to:
Number of uses:
per prescription per year

Form more information phone: 855-452-5234 or Visit website

Pemazyre IncyteCARES Temporary Access Program: Eligible commercially insured patient may receive a FREE 30-day supply if experiencing a delay in coverage; for additional information contact the program at 855-452-5234.

Applies to:
Number of uses:
Contact the program

Form more information phone: 855-452-5234 or Visit website

Patient Assistance Programs for Pemazyre

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Pemazyre (pemigatinib) Tablet

More information please phone: 866-316-7263 Visit Website

Provider: IncyteCARES Patient Assistance Program (Pemazyre)

Elligibility requirements:
  1. Must be uninsured or underinsured
  2. Gross family household income at or less than $125,000 or 600% FPL, whichever is greater
  3. FDA-approved diagnosis
  4. Must live in United States or Puerto Rico
  5. Patient or doctor's office can call the program to apply. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Conditional approval for 90 days. Education and support services are available. This program also provides copay/coinsurance assistance for commercially/privately insured patients Prescribers can enroll the patient online via the website.
Applicable drugs:
  • Pemazyre (pemigatinib) Tablet

More information please phone: 855-452-5234 Visit Website